APO Research
Talk to an analyst

APO RESEARCH · REPORT

Montelukast API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Montelukast API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025196 pages

Choose your research edition.

Industry ResearchMontelukast API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast API Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Montelukast API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Montelukast API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Montelukast API include Merck, Mylan, Teva Pharmaceutical Industries, Sun Pharma, Sanyo Chemical Industries, Morepen Laboratories, Intas Pharmaceuticals, Delmar Chemicals and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Montelukast API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Montelukast API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Montelukast API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Montelukast API market size, projected growth trends, production technologies, key applications, and end-use industries.

Montelukast API Segment by Company

Merck

Mylan

Teva Pharmaceutical Industries

Sun Pharma

Sanyo Chemical Industries

Morepen Laboratories

Intas Pharmaceuticals

Delmar Chemicals

Cipla

Apotex

Montelukast API Segment by Type

Chewable Tablet

Oral Solution

Tablet

Montelukast API Segment by Application

Bronchospasm

Urticaria

Asthma

Allergic Rhinitis

Others

Montelukast API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Montelukast API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Montelukast API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Montelukast API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Montelukast API Industry Trends Table 2. Montelukast API Industry Drivers Table 3. Montelukast API Industry Opportunities and Challenges Table 4. Montelukast API Industry Restraints Table 5. Global Montelukast API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Montelukast API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Montelukast API Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Montelukast API Sales Market Share by Manufacturers Table 9. Global Montelukast API Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Montelukast API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Montelukast API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Montelukast API Manufacturers, Product Type & Application Table 13. Global Montelukast API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Montelukast API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Chewable Tablet Table 17. Major Manufacturers of Oral Solution Table 18. Major Manufacturers of Tablet Table 19. Global Montelukast API Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Montelukast API Sales by Type (2021-2026) & (K Units) Table 21. Global Montelukast API Sales by Type (2027-2032) & (K Units) Table 22. Global Montelukast API Sales Market Share by Type (2021-2026) Table 23. Global Montelukast API Sales Market Share by Type (2027-2032) Table 24. Global Montelukast API Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Montelukast API Revenue by Type (2021-2026) & (K Units) Table 26. Global Montelukast API Revenue by Type (2027-2032) & (K Units) Table 27. Global Montelukast API Revenue Market Share by Type (2021-2026) Table 28. Global Montelukast API Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Bronchospasm Table 30. Major Manufacturers of Urticaria Table 31. Major Manufacturers of Asthma Table 32. Major Manufacturers of Allergic Rhinitis Table 33. Major Manufacturers of Others Table 34. Global Montelukast API Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Montelukast API Sales by Application (2021-2026) & (K Units) Table 36. Global Montelukast API Sales by Application (2027-2032) & (K Units) Table 37. Global Montelukast API Sales Market Share by Application (2021-2026) Table 38. Global Montelukast API Sales Market Share by Application (2027-2032) Table 39. Global Montelukast API Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Montelukast API Revenue by Application (2021-2026) & (K Units) Table 41. Global Montelukast API Revenue by Application (2027-2032) & (K Units) Table 42. Global Montelukast API Revenue Market Share by Application (2021-2026) Table 43. Global Montelukast API Revenue Market Share by Application (2027-2032) Table 44. Global Montelukast API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Montelukast API Sales by Region (2021-2026) & (K Units) Table 46. Global Montelukast API Sales Market Share by Region (2021-2026) Table 47. Global Montelukast API Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Montelukast API Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Montelukast API Sales by Country (2021-2026) & (K Units) Table 51. North America Montelukast API Sales by Country (2027-2032) & (K Units) Table 52. Europe Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Montelukast API Sales by Country (2021-2026) & (K Units) Table 54. Europe Montelukast API Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Montelukast API Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Montelukast API Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Montelukast API Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Montelukast API Sales by Country (2027-2032) & (K Units) Table 61. Global Montelukast API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Montelukast API Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Montelukast API Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Montelukast API Revenue Market Share by Region (2021-2026) Table 65. Global Montelukast API Revenue Market Share by Region (2027-2032) Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Merck Montelukast API Product Portfolio Table 70. Merck Recent Development Table 71. Mylan Company Information Table 72. Mylan Business Overview Table 73. Mylan Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Mylan Montelukast API Product Portfolio Table 75. Mylan Recent Development Table 76. Teva Pharmaceutical Industries Company Information Table 77. Teva Pharmaceutical Industries Business Overview Table 78. Teva Pharmaceutical Industries Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Teva Pharmaceutical Industries Montelukast API Product Portfolio Table 80. Teva Pharmaceutical Industries Recent Development Table 81. Sun Pharma Company Information Table 82. Sun Pharma Business Overview Table 83. Sun Pharma Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sun Pharma Montelukast API Product Portfolio Table 85. Sun Pharma Recent Development Table 86. Sanyo Chemical Industries Company Information Table 87. Sanyo Chemical Industries Business Overview Table 88. Sanyo Chemical Industries Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sanyo Chemical Industries Montelukast API Product Portfolio Table 90. Sanyo Chemical Industries Recent Development Table 91. Morepen Laboratories Company Information Table 92. Morepen Laboratories Business Overview Table 93. Morepen Laboratories Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Morepen Laboratories Montelukast API Product Portfolio Table 95. Morepen Laboratories Recent Development Table 96. Intas Pharmaceuticals Company Information Table 97. Intas Pharmaceuticals Business Overview Table 98. Intas Pharmaceuticals Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Intas Pharmaceuticals Montelukast API Product Portfolio Table 100. Intas Pharmaceuticals Recent Development Table 101. Delmar Chemicals Company Information Table 102. Delmar Chemicals Business Overview Table 103. Delmar Chemicals Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Delmar Chemicals Montelukast API Product Portfolio Table 105. Delmar Chemicals Recent Development Table 106. Cipla Company Information Table 107. Cipla Business Overview Table 108. Cipla Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Cipla Montelukast API Product Portfolio Table 110. Cipla Recent Development Table 111. Apotex Company Information Table 112. Apotex Business Overview Table 113. Apotex Montelukast API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Apotex Montelukast API Product Portfolio Table 115. Apotex Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Montelukast API Distributors List Table 119. Montelukast API Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Montelukast API Product Image Figure 2. Global Montelukast API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast API Market Size (2021-2032) & (US$ Million) Figure 4. Global Montelukast API Sales (2021-2032) & (K Units) Figure 5. Global Montelukast API Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Montelukast API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Chewable Tablet Image Figure 9. Oral Solution Image Figure 10. Tablet Image Figure 11. Global Montelukast API Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Montelukast API Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Montelukast API Sales Market Share by Type (2021-2032) Figure 14. Global Montelukast API Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Montelukast API Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Montelukast API Revenue Market Share by Type (2021-2032) Figure 17. Bronchospasm Image Figure 18. Urticaria Image Figure 19. Asthma Image Figure 20. Allergic Rhinitis Image Figure 21. Others Image Figure 22. Global Montelukast API Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Montelukast API Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Montelukast API Sales Market Share by Application (2021-2032) Figure 25. Global Montelukast API Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Montelukast API Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Montelukast API Revenue Market Share by Application (2021-2032) Figure 28. North America Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Montelukast API Sales Market Share by Country (2021-2032) Figure 30. U.S. Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Montelukast API Sales Market Share by Country (2021-2032) Figure 35. Germany Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Montelukast API Sales Market Share by Country (2021-2032) Figure 42. China Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Montelukast API Sales Market Share by Country (2021-2032) Figure 50. Brazil Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Montelukast API Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Montelukast API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Montelukast API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Montelukast API Revenue (2021-2032) & (US$ Million) Figure 61. North America Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Montelukast API Revenue (2021-2032) & (US$ Million) Figure 63. Europe Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Montelukast API Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Montelukast API Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Montelukast API Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Montelukast API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Chewable Tablet
  • Oral Solution
  • Tablet
Applications
  • Bronchospasm
  • Urticaria
  • Asthma
  • Allergic Rhinitis
  • Others
Companies covered
  • Merck
  • Mylan
  • Teva Pharmaceutical Industries
  • Sun Pharma
  • Sanyo Chemical Industries
  • Morepen Laboratories
  • Intas Pharmaceuticals
  • Delmar Chemicals
  • Cipla
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Montelukast API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Montelukast API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Montelukast API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Montelukast API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Montelukast API Market Dynamics
  1. 2.1 Montelukast API Industry Trends
  2. 2.2 Montelukast API Industry Drivers
  3. 2.3 Montelukast API Industry Opportunities and Challenges
  4. 2.4 Montelukast API Industry Restraints
3 Montelukast API Market by Manufacturers
  1. 3.1 Global Montelukast API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Montelukast API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Montelukast API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Montelukast API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Montelukast API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Montelukast API Manufacturers, Product Type & Application
  7. 3.7 Global Montelukast API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Montelukast API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Montelukast API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Montelukast API Tier 1, Tier 2, and Tier 3
4 Montelukast API Market by Type
  1. 4.1 Montelukast API Type Introduction
  2. 4.1.1 Chewable Tablet
  3. 4.1.2 Oral Solution
  4. 4.1.3 Tablet
  5. 4.2 Global Montelukast API Sales by Type
  6. 4.2.1 Global Montelukast API Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Montelukast API Sales by Type (2021-2032)
  8. 4.2.3 Global Montelukast API Sales Market Share by Type (2021-2032)
  9. 4.3 Global Montelukast API Revenue by Type
  10. 4.3.1 Global Montelukast API Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Montelukast API Revenue by Type (2021-2032)
  12. 4.3.3 Global Montelukast API Revenue Market Share by Type (2021-2032)
5 Montelukast API Market by Application
  1. 5.1 Montelukast API Application Introduction
  2. 5.1.1 Bronchospasm
  3. 5.1.2 Urticaria
  4. 5.1.3 Asthma
  5. 5.1.4 Allergic Rhinitis
  6. 5.1.5 Others
  7. 5.2 Global Montelukast API Sales by Application
  8. 5.2.1 Global Montelukast API Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Montelukast API Sales by Application (2021-2032)
  10. 5.2.3 Global Montelukast API Sales Market Share by Application (2021-2032)
  11. 5.3 Global Montelukast API Revenue by Application
  12. 5.3.1 Global Montelukast API Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Montelukast API Revenue by Application (2021-2032)
  14. 5.3.3 Global Montelukast API Revenue Market Share by Application (2021-2032)
6 Global Montelukast API Sales by Region
  1. 6.1 Global Montelukast API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Montelukast API Sales by Region (2021-2032)
  3. 6.2.1 Global Montelukast API Sales by Region (2021-2026)
  4. 6.2.2 Global Montelukast API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Montelukast API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Montelukast API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Montelukast API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Montelukast API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Montelukast API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Montelukast API Revenue by Region
  1. 7.1 Global Montelukast API Revenue by Region
  2. 7.1.1 Global Montelukast API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Montelukast API Revenue by Region (2021-2026)
  4. 7.1.3 Global Montelukast API Revenue by Region (2027-2032)
  5. 7.1.4 Global Montelukast API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Montelukast API Revenue (2021-2032)
  8. 7.2.2 North America Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Montelukast API Revenue (2021-2032)
  11. 7.3.2 Europe Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Montelukast API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Montelukast API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Montelukast API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Montelukast API Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Montelukast API Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Teva Pharmaceutical Industries
  14. 8.3.1 Teva Pharmaceutical Industries Company Information
  15. 8.3.2 Teva Pharmaceutical Industries Business Overview
  16. 8.3.3 Teva Pharmaceutical Industries Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceutical Industries Montelukast API Product Portfolio
  18. 8.3.5 Teva Pharmaceutical Industries Recent Developments
  19. 8.4 Sun Pharma
  20. 8.4.1 Sun Pharma Company Information
  21. 8.4.2 Sun Pharma Business Overview
  22. 8.4.3 Sun Pharma Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharma Montelukast API Product Portfolio
  24. 8.4.5 Sun Pharma Recent Developments
  25. 8.5 Sanyo Chemical Industries
  26. 8.5.1 Sanyo Chemical Industries Company Information
  27. 8.5.2 Sanyo Chemical Industries Business Overview
  28. 8.5.3 Sanyo Chemical Industries Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanyo Chemical Industries Montelukast API Product Portfolio
  30. 8.5.5 Sanyo Chemical Industries Recent Developments
  31. 8.6 Morepen Laboratories
  32. 8.6.1 Morepen Laboratories Company Information
  33. 8.6.2 Morepen Laboratories Business Overview
  34. 8.6.3 Morepen Laboratories Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Morepen Laboratories Montelukast API Product Portfolio
  36. 8.6.5 Morepen Laboratories Recent Developments
  37. 8.7 Intas Pharmaceuticals
  38. 8.7.1 Intas Pharmaceuticals Company Information
  39. 8.7.2 Intas Pharmaceuticals Business Overview
  40. 8.7.3 Intas Pharmaceuticals Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Intas Pharmaceuticals Montelukast API Product Portfolio
  42. 8.7.5 Intas Pharmaceuticals Recent Developments
  43. 8.8 Delmar Chemicals
  44. 8.8.1 Delmar Chemicals Company Information
  45. 8.8.2 Delmar Chemicals Business Overview
  46. 8.8.3 Delmar Chemicals Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Delmar Chemicals Montelukast API Product Portfolio
  48. 8.8.5 Delmar Chemicals Recent Developments
  49. 8.9 Cipla
  50. 8.9.1 Cipla Company Information
  51. 8.9.2 Cipla Business Overview
  52. 8.9.3 Cipla Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cipla Montelukast API Product Portfolio
  54. 8.9.5 Cipla Recent Developments
  55. 8.10 Apotex
  56. 8.10.1 Apotex Company Information
  57. 8.10.2 Apotex Business Overview
  58. 8.10.3 Apotex Montelukast API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Apotex Montelukast API Product Portfolio
  60. 8.10.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Montelukast API Value Chain Analysis
  2. 9.1.1 Montelukast API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Montelukast API Production Mode & Process
  6. 9.2 Montelukast API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Montelukast API Distributors
  9. 9.2.3 Montelukast API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst